India’s financial services companies including banks and non-banking finance companies (NBFCs) have seen record foreign direct investment (FDI) flowing in the current calendar year. businessline takes a re-look at some of the largest deals in 2025:Shriram Finance-MUFG dealOn December 19, India’s second largest NBFC Shriram Finance said it has entered into definitive agreement with Japan’s largest lender MUFG Bank wherein the latter will pick 20 per cent stake in the NBFC for ₹39,618 crore. This is the large ...

India’s financial sector has seen a number of large deals in 2025, ‍including rare transactions involving foreign banks buying significant stakes in Indian lenders.Between January and September ​2025, mergers and acquisitions worth $8 billion had concluded across the financial ‌sector, a 127 per cent increase over the same period last year, ​according to data by Grant Thornton.Here are key facts about the major deals:MUFG - SHRIRAM FINANCEJapan’s MUFG will pick up a 20 per cent stake in Shriram Finance for ...

California Pizza Kitchen (CPK) is to be acquired by an investor group led by Consortium Brand Partners, with Convive Brands CEO Jon Weber appointed to lead the chain’s restaurant operations, as reported by Reuters. The deal comes five years after CPK entered bankruptcy during the pandemic, when a sales slowdown and high debt levels led the company to seek protection in July 2020. Lenders took ownership of the business following that process. Under the new structure, Weber - whose Convive Brands is part ...

During D’Souza’s tenure, Cognizant carved out a strong franchise in healthcare, with the former CEO playing a pivotal role in the $2.7 billion all-cash acquisition of TriZetto in 2014 — a landmark deal that anchored Cognizant’s healthtech ambitions. TriZetto’s platform connects with 11,000 payers and processes more than 4 billion transactions a year.Early in its growth journey, Cognizant rapidly expanded its healthcare presence, counting nine of the top 10 payers — including United, Anthem, Cigna, and Aetna ...

EcoCeres, a producer of sustainable fuel backed by Bain Capital, is considering an IPO in Hong Kong instead of London https://t.co/bIWZI6jrlH ...

Private market firm Bain Capital and Japan’s Sumitomo Mitsui Banking Corp. are joining forces for a new European loan platform targeting corporate borrowers in Europe and UK https://t.co/AXBZpMCPOz ...

Core Insights - The private equity industry is experiencing significant consolidation, with a notable increase in capital flowing to the largest funds [1][2][8] Fundraising Trends - In 2025, nearly 46% of all private equity capital raised has been secured by the 10 largest funds, up from 34.5% in 2024, with predictions indicating that over 40% will go to the largest funds in 2026 [2] - Total fundraising has decreased substantially, with only $259 billion raised so far this year compared to $372.6 billion last year, marking an 8% year-over-year drop in the absolute amount raised by the top funds to $118.3 billion [3][5] Share of Top Funds - The top 10 funds are capturing a larger share of the fundraising haul than in the past decade, with their share rising to 45.7% this year from an average of 35.8% over the last five years [4][5] - The three largest funds raised $60.4 billion this year, accounting for 23.3% of the total amount raised, compared to $55.9 billion last year, which was only 15% of the total [7] Notable Funds - The top 10 funds include Thoma Bravo Fund XVI ($24.3 billion), Blackstone Capital Partners IX ($21 billion), and Veritas Capital Fund IX ($14.4 billion), among others [6]

Market Overview - Asia-Pacific markets opened higher, influenced by Wall Street gains and expectations of a potential U.S. Federal Reserve interest rate cut in December [1][3] - Markets are pricing in over an 84% chance of a Fed rate cut in December, with New York Fed President indicating room for lower rates "in the near term" [3] Company Performance - Kioxia's shares fell more than 12% following reports that Bain Capital plans to sell approximately 350 billion yen ($2.24 billion) worth of shares, reducing its ownership from 51% to 44% [4] - Kioxia reported fiscal second-quarter earnings that missed expectations, leading to a 23.03% drop in its shares the following day [5] Regional Market Movements - Japanese tech stocks saw gains, with Advantest rising 2.5% and Tokyo Electron increasing by 0.61% [3] - South Korea's Kospi advanced by 0.67%, while the small-cap Kosdaq climbed 0.64% [5] - Australia's ASX/S&P 200 was trading 1.2% higher, with inflation accelerating in October, marking the fastest pace in seven months [5][6]

A Bain Capital-backed entity will dump a stake in Kioxia Holdings in a block trade as the stock has surged since its initial public offering about a year ago https://t.co/5hgpRpR9UV ...

Core Insights - Bain Capital has sold its entire stake in Disc Medicine, indicating a shift in sentiment towards the biotech company [4][5][6] - Disc Medicine focuses on developing innovative therapies for rare hematologic diseases, leveraging scientific expertise in red blood cell biology [3][5] - Despite Bain's exit, Disc Medicine's stock has continued to perform well, reaching a 52-week high [5][6] Company Overview - Disc Medicine is a biotechnology firm that targets rare and severe blood disorders, primarily serving healthcare providers and hospitals [1][3] - The company operates on a research-driven model, investing in the discovery and clinical development of novel treatments [2][3] Financial Performance - As of November 14, 2025, Disc Medicine shares were priced at $89.95, reflecting a 48.3% increase over the past year, outperforming the S&P 500 by 30.13 percentage points [4][5] - The complete sale by Bain Capital resulted in a net reduction of $30,902,160, with the position previously accounting for approximately 3.9% of the fund's assets under management [5][6] Market Implications - The exit of a significant institutional player like Bain Capital may signal potential skepticism regarding future growth prospects for Disc Medicine [6][7] - Retail investors should be aware of this development, as it could indicate broader market sentiment towards the company [7]